| RS1555350254 |
OTX2
|
Health Risk |
Pathogenic |
Anophthalmia, Anophthalmia |
| RS1555350397 |
OTX2
|
Health Risk |
Likely pathogenic |
9 conditions, 9 conditions |
| RS1555351849 |
POMT2
|
Health Risk |
Likely pathogenic |
— |
| RS1555351889 |
POMT2
|
Health Risk |
Likely pathogenic |
— |
| RS1555351894 |
POMT2
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1555352516 |
PSMA3
|
Health Risk |
Pathogenic |
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC |
| RS1555352529 |
NEK9
|
Health Risk |
Pathogenic |
Nevus comedonicus syndrome, Nevus comedonicus syndrome |
| RS1555352706 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1555353410 |
PSMA3
|
Health Risk |
Pathogenic |
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC |
| RS1555354172 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Autosomal recessive limb-girdle muscular dystrophy type 2N |
| RS1555354198 |
SRP54
|
Health Risk |
Pathogenic/Likely pathogenic |
Shwachman-Diamond syndrome 1, Neutropenia |
| RS1555354200 |
SRP54
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Neutropenia |
| RS1555354564 |
PSEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1555354581 |
PSEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1555354750 |
SRP54
|
Health Risk |
Pathogenic/Likely pathogenic |
Shwachman-Diamond syndrome 1, Neutropenia |
| RS1555355250 |
PSEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia, Acne inversa |
| RS1555355289 |
PSEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1555356398 |
POMT2
|
Health Risk |
Likely pathogenic |
Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies, Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies |
| RS1555357544 |
PSEN1
|
Health Risk |
Pathogenic |
Alzheimer disease 3, Pick disease |
| RS1555358260 |
PSEN1
|
Health Risk |
Likely pathogenic |
Alzheimer disease 3, Alzheimer disease 3 |
| RS1555358382 |
GCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, GTP cyclohydrolase I deficiency |
| RS1555358507 |
GCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555358599 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555358604 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555358729 |
COQ6
|
Health Risk |
Pathogenic |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Familial steroid-resistant nephrotic syndrome with sensorineural deafness |
| RS1555360027 |
TGFB3
|
Health Risk |
Likely pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS1555360034 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555360047 |
TGFB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rienhoff syndrome, Arrhythmogenic right ventricular dysplasia 1 |
| RS1555360050 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555360212 |
TGFB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Rienhoff syndrome |
| RS1555360222 |
TGFB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS1555360229 |
TGFB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Rienhoff syndrome |
| RS1555360362 |
TGFB3
|
Health Risk |
Likely pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS1555360368 |
TGFB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Rienhoff syndrome |
| RS1555360883 |
TGFB3
|
Health Risk |
Likely pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS1555361385 |
TGFB3
|
Health Risk |
Pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS1555361451 |
TGFB3
|
Health Risk |
Pathogenic |
— |
| RS1555361758 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1555361990 |
FANCM
|
Health Risk |
Likely pathogenic |
— |
| RS1555362835 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS1555362843 |
GCH1
|
Health Risk |
Likely pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1555362845 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1555362905 |
GCH1
|
Health Risk |
Likely pathogenic |
— |
| RS1555362907 |
GCH1
|
Health Risk |
Pathogenic |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1555363275 |
FANCM
|
Health Risk |
Pathogenic |
Spermatogenic failure 28, Spermatogenic failure 28 |
| RS1555363969 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555364149 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555364153 |
ATL1
|
Health Risk |
Likely pathogenic |
— |
| RS1555364246 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555364247 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555364837 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1555364979 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS1555365509 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555365512 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555365595 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555365597 |
ATL1
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory |
| RS1555365850 |
ATL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555365854 |
ATL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1555365959 |
FANCM
|
Health Risk |
Pathogenic |
Spermatogenic failure 28, Spermatogenic failure 28 |
| RS1555366045 |
CALM1
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 4, Long QT syndrome 14 |
| RS1555366197 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555366309 |
SIX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootic syndrome 3, Autosomal dominant nonsyndromic hearing loss 23 |
| RS1555366438 |
VIPAS39
|
Health Risk |
Likely pathogenic |
Arthrogryposis, renal dysfunction |
| RS1555366592 |
SPTB
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis, Hereditary spherocytosis |
| RS1555366607 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis, Hereditary spherocytosis |
| RS1555366979 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1555367318 |
SPTB
|
Health Risk |
Pathogenic |
Hemolytic anemia, Hemolytic anemia |
| RS1555367359 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS1555367522 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555367601 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1555367789 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS1555367891 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555367892 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555367896 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555367897 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555367924 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1555367927 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555368345 |
GABRB3
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 43 |
| RS1555368535 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555368557 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, SERPINA1-related disorder |
| RS1555368626 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS1555368636 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS1555368749 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nonsyndromic Oculocutaneous Albinism, Nonsyndromic Oculocutaneous Albinism |
| RS1555368758 |
SERPINA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555368900 |
YY1
|
Health Risk |
Likely pathogenic |
— |
| RS1555369050 |
IFT43
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 18 with polydactyly, Short rib-polydactyly syndrome |
| RS1555369128 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555369172 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555369299 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1555369473 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1555369579 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555369632 |
DICER1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1555369657 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS1555370248 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555370268 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1555370297 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1555370456 |
MKRN3
|
Health Risk |
Likely pathogenic |
— |
| RS1555370458 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS1555370776 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1555370787 |
FGF14
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 27, Spinocerebellar ataxia 27A |